Matthew Lin, MD
About Me
Dr. Matthew J. Lin is Assistant Clinical Professor of Dermatology in the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. He is dual fellowship trained in both dermatologic surgery and Mohs micrographic surgery.
Dr. Lin is a recognized expert in basal cell carcinoma, squamous cell carcinoma, melanoma, Mohs micrographic surgery, reconstructive surgery, cosmetic surgery and scar management. He has received multiple grants and awards for his clinical and translational research in the field. His work has been published extensively in the medical literature including in Clinics in Dermatology, Journal of the American Academy of Dermatology, Dermatologic Surgery, Journal of Cutaneous Medicine and Surgery, Journal of Dermatologic Treatment, Cutis, British Medical Journal and Journal of the European Academy of Dermatology and Venerology. As part of his academic activities he serves on the editorial board for several journals including Dermatologic Surgery.
Dr. Lin is a Fellow of the American Academy of Dermatology and the American Society of Dermatologic Surgery. He is a member of the American College of Mohs Surgery.
CLINICAL FOCUS
• Actinic Keratosis
• Basal Cell Carcinoma
• Birthmarks
• Botulinum Toxin
• Cosmetic Surgery
• Dermabrasion
• Dermoscopy
• Dysplastic Nevi
• Hyperhidrosis
• Injectable fillers
• Keloid
• Laser Resurfacing
• Lipoma
• Liposuction
• Melanoma
• Microneedling
• Mohs Micrographic Surgery
• Nevi
• Platelet Rich Plasma
• Scars
• Squamous Cell Carcinoma
• Sun Damage
• Sunburn
• Vascular Laser
EDUCATION
MD, The University of Melbourne
Residency, Dermatology
Oxford University Hospitals NHS Trust
Residency, Dermatology
Australasian College of Dermatologists
Fellowship, Mohs Micrographic Surgery
Icahn School of Medicine at Mount Sinai
LANGUAGE
English
Language
English
Position
ASSISTANT CLINICAL PROFESSOR | Dermatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Lin has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.